Document Detail


Pulmonary failure as a cause of death in COPD.
MedLine Citation:
PMID:  9203816     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Data on the outcome of patients with chronic obstructive pulmonary disease (COPD) are limited. We know that the prognosis is poor when respiratory insufficiency develops, but we have little information on the actual cause of death. Epidemiological studies are suitable for the assessment of the prevalence of the disease, but give no details on the actual cause of death. Age and forced expiratory volume in one second (FEV1) have been recognized as the best predictors of mortality in studies designed to quantify survival of COPD patients, particularly when the post-brochodilator value is used, as this provides a better estimate of airway and parenchymal damage. Data from Intensive Care Units on acute respiratory failure have several significant limitations. Firstly, it is probable that some patients elect not to undergo intensive treatment for a terminal bout of respiratory failure, particularly if it is not first episode. Secondly, the actual cause of death is often not described in adequate detail. Hypoxaemia and acidaemia are the main risk factors in acute exacerbation of the disease and the presence of pulmonary infiltrates on chest radiographs worsens the prognosis. A single bout of respiratory failure appears to have no effect on the prognosis of COPD patients after recovery, but there is a consistent increase in mortality after the second episode. It seems possible to manage the majority of episodes of acute respiratory failure with mechanical ventilation administered with noninvasive techniques. When endotracheal intubation is necessary, the prognosis is usually poor and the survival after 1 yr is usually lower than 40%. The role of long-term home mechanical ventilation is still unclear. Results from pivotal studies have been encouraging, although survival is far less impressive than in neuromuscular disorders. In patients with end-stage lung disease, lung transplantation can be considered the only possibility of increasing pulmonary functional capacity. However the technique is reserved only for a highly selected group of patients and data on the long-term outcome are awaited.
Authors:
A Braghiroli; S Zaccaria; F Ioli; M Erbetta; C F Donner
Related Documents :
17875066 - When should home mechanical ventilation be started in patients with different neuromusc...
2029286 - Acute gestational pyelonephritis: the impact on colloid osmotic pressure, plasma fibron...
9671366 - A prospective study of unplanned endotracheal extubation in intensive care unit patients.
8857116 - Pulmonary oedema, pneumonia and mortality in submersion victims; a retrospective study ...
11923606 - Increased adhesion molecule expression in serosal fibroblasts isolated from patients wi...
15557406 - Information and participation preferences of dental patients.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo     Volume:  52     ISSN:  1122-0643     ISO Abbreviation:  Monaldi Arch Chest Dis     Publication Date:  1997 Apr 
Date Detail:
Created Date:  1997-07-29     Completed Date:  1997-07-29     Revised Date:  2008-06-02    
Medline Journal Info:
Nlm Unique ID:  9307314     Medline TA:  Monaldi Arch Chest Dis     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  170-5     Citation Subset:  IM    
Affiliation:
Division of Respiratory Disease, Salvatore Maugeri Foundation, IRCCS, Medical Center of Rehabilitation, Veruno, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Cause of Death
Humans
Lung Diseases, Obstructive / complications,  mortality*,  therapy
Prognosis
Respiration, Artificial
Respiratory Insufficiency / complications,  mortality*,  therapy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Growth factors in asthma.
Next Document:  Transcription factors as activators of gene transcription: AP-1 and NF-kappa B.